Mortality rate from early prostate cancer increased 3-fold after 15 years following the diagnosis

Johansson, J.E.
January 2005
ACP Journal Club;Jan/Feb2005, Vol. 142 Issue 1, p24
Academic Journal
The article reports that mortality rate from early prostate cancer increased 3-fold after 15 years following the diagnosis. Progression of disease, and death from prostate cancer and all-cause mortality. Multivariable analysis showed that the risk for death from prostate cancer was greater after 15 years of follow-up than during the first five years and was greater among patients with grade three tumors than among those with grade one tumors. In men with early prostate cancer, the mortality rate from cancer increased 3-fold after 15 years of follow-up.


Related Articles

  • Malignant Neoplasms of Male Genital Organs (C60-C63) in the Os iek-Baranja County, Croatia. Milas, Josip; Samardžić, Senka; Milas, Krešimir // Collegium Antropologicum;2014, Vol. 38 Issue 3, p949 

    Cancers of male genital organs (C60-C63) and in particular, prostate cancer, represent one of the most frequent cancer groups among males in economically developed countries and growing cancer group in developing countries. The Institute of Public Health of the Osijek-Baranja County in...

  • T2-weighted MR imaging of prostate cancer: multishot echo-planar imaging vs fast spin-echo imaging. Tamada, Tsutomu; Sone, Teruki; Nagai, Kiyohisa; Jo, Yoshimasa; Gyoten, Masayuki; Imai, Shigeki; Kajihara, Yasumasa; Fukunaga, Masao // European Radiology;Feb2004, Vol. 14 Issue 2, p318 

    The aim of the present study was to assess the performance of pre-biopsy T2-weighted MR imaging using multishot echo-planar imaging (EPI) sequence for visualization of prostate cancer and to compare image quality with that of fast spin-echo (FSE) sequence. Thirty-nine patients with suspected...

  • In Brief.  // Urology Times;2/1/2005, Vol. 33 Issue 2, p5 

    Reports developments on urology. Increase in the risk of prostate cancer patients on androgen-deprivation therapy to bone fractures; Relation between the alpha-blocker tamsulosin and a new small pupil syndrome known as intraoperative floppy iris syndrome; Decrease in the mortality rate of...

  • Does testing for prostate-specific antigen contribute to declining prostate cancer mortality? Di Matteo, L.; Di Matteo, R. // European Journal of Health Economics;Dec2005, Vol. 6 Issue 4, p298 

    Key variables associated with prostate cancer mortality were examined using Canadian province level time-series data over the period 1979–1999 in a multiple regression framework. The key variables driving the prostate cancer mortality rate are per capita income, per capita number of...

  • Annual screening for prostate cancer did not reduce mortality from prostate cancer.  // Evidence Based Medicine;Aug2009, Vol. 14 Issue 4, p104 

    The article examines the effectiveness of annual screening for prostate cancer in reducing mortality rate. Based on randomised controlled trials conducted to 76,693 men ranging from 55 to 74-years-old was considered to be a positive result. Meanwhile, the result shows that the incidence and...

  • Pre-treatment PSA velocity predicts recurrence risk. Bankhead, Charles // Urology Times;8/15/2004, Vol. 32 Issue 12, p1 

    Reports that a preoperative rise in serum prostate specific antigen of >2.0 ng⁄ml predicts an increased mortality risk in patients with localized prostate cancer undergoing a radical prostatectomy and might identify men who require additional therapy in Boston, as concluded by...

  • Attacking the Prostate-Cancer Gene. Geraci, Ron // Men's Health;Dec99, Vol. 14 Issue 10, p60 

    Provides information on the defective gene of prostate cancer.

  • Vigorous Activity May Slow the Pace of Prostate Cancer.  // Cortlandt Forum;10/26/2005 Supplement, Vol. 18, p3 

    The article reports that researchers at the Harvard School of Public Health have reported that approximately 3 hours or more of vigorous activity a week may slow the progression of prostate cancer. The association was noted only in men less than sixty five years old. During the 14-year long...

  • Prostate cancer: an update. Chinegwundoh, F. // Caribbean Health;Dec2001, Vol. 4 Issue 6, p6 

    The article offers updates on the medical concept and treatment of prostate cancer. Prostate cancer is believed to be the second most common cause of male cancer mortality in Europe and America. An expert suggests that black men may have a more aggressive variant of prostate cancer, for reasons...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics